Professor Margaret Cruickshank
Personal Chair (Clinical)
Aberdeen Centre for Women's Health Reserch, Aberdeen Maternity Hospital ABERDEEN AB25 2ZD
Maggie Cruickshank has a personal chair in Gynaecology at the University of Aberdeen and is an Honorary Consultant Gynaecologist at Aberdeen Royal Infirmary. She is the Direcotor of Research and Development for NHS Grampian.
My clinical practice focuses on lower genital tract disease. I am past President and a trustee of the British Society for Colposcopy and Cervical Pathology (BSCCP) and President-elect of the European Federation of Colposcopy and Cervical Pathology (EFC). I currently co-chairs the Education and Training Committee of the International Federation of Colposcopy and Cervical Pathology (IFCPC). I have an interest in medical education and clinical training and lead on training the trainers and assessment of colposcopy training IFCPC.
My research portfolio focuses on the management of women with lower genital tract intra-epithelial neoplasia and the impact of HPV vaccination on HPV-related disease and colposcopy performance and delivery.
Professor Maggie Cruickshank is Director of NHS Grampian Research and Development
I have a programme of research in pre-invasive disease of the lower genital tract including cervix, vagina, vulva and anus. The focus of this work relates to Human Papillomavirus infection (HPV) and cervical cancer prevention. My studies include observational studies with data linakage and clinical trials.
My main research interests include the impact of HPV immunisation on lower genital tract disease and on colposcopy performance and service delivery.
The collaborators in our research programme have set up a Scottish HPV Investigators Research Network (SHINe) to promote collaboration and the development of HPV research. This includes the development of a national HPV archive funded by CSO BTR programme grant and collaboration to optimise our research strategy with the HPV surveillance work of Health Protection Scotland. I work with collaborators from Universities of Edinburgh and Starthclyde, NHS Grampian, Lothian and Lanarkshire and Health Protection Scotland.
Funding and Grants
2011-2015: HTA (Grant holder). Strategies to Increase Cervical Screening Uptake at First Invitation (STRATEGIC). Universities of Aberdeen and Manchester
2010- 2016: CSO HSR Programme grant (Principal investigator) Long-term Follow-up of HPV vaccination in women attending first cervical smear: the impact of HPV immunisation on cervical screening and the prevention of HPV-related disease in Scottish women.
2009-2014: CSO BTR Programme grant (Grant holder) Long-term Follow-up of HPV vaccination in women attending first cervical smear – establishment and development of HPV research base.
Professor Maggie Cruickshank co-orodinates specialist teaching in Obstetrics and Gynaecology for years 3-5 of the MB ChB course and the Physicians Associates courses.
Page 1 of 10 Results 1 to 10 of 100
Clinical performance of primary HPV screening cut-off for colposcopy referrals in HPV vaccinated cohort: Literature Review and observational studyBJOG-An International Journal of Obstetrics and GynaecologyContributions to Journals: Articles
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar LesionsJournal of Lower Genital Tract DiseaseContributions to Journals: Articles
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statetextellipsisInternational Journal of Gynecological CancerContributions to Journals: Articles
The Swedescore: structured image scoring in routine colposcopy practice adds to risk assessmentBJOG-An International Journal of Obstetrics and GynaecologyContributions to Journals: Articles
Cervical cancers avoided by HPV immunisationThe Lancet, vol. 398, no. 10361, pp. P2053-2055Contributions to Journals: Comments and Debates
Invasive cervical cancer following treatment of pre-invasive lesions: a potential theory based on a small case seriesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 264, pp. 56-59Contributions to Journals: Articles
Has the human papillomavirus (HPV) immunization programme improved obstetric outcomes in spontaneous delivery?: An ecological studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 262, pp. 221-227Contributions to Journals: Articles
Cervical cancer prevention in transgender men: a reviewBJOG-An International Journal of Obstetrics and Gynaecology, vol. 128, no. 5, pp. 822-826Contributions to Journals: Review articles
Options for triage and implications for colposcopists within European HPV-based cervical screening programmesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 258, pp. 332-342Contributions to Journals: Articles
Effect of sequential rounds of cervical cancer screening on management of HPV-positive women: A 15-year population-based cohort study from ChinaCancer Prevention Research, vol. 14, no. 3, pp. 363–72Contributions to Journals: Articles